Clinical Trial Update: Effects of Xiidra on Closed Eye Tear Film Leukocytes in Dry Eye Disease [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial investigating the effects of Xiidra on closed-eye tear film leukocytes in dry eye disease was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease
• Keratoconjunctivitis Sicca
• Ocular Discomfort
• Ocular Inflammation

Drugs mentioned

• Xi-idra (lifitegrast)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Ocular Discomfort, Ocular Inflammation | Phase 4 | Status: WITHDRAWN